These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23375512)

  • 1. Single vs composite measures of pain intensity: relative sensitivity for detecting treatment effects.
    Jensen MP; Hu X; Potts SL; Gould EM
    Pain; 2013 Apr; 154(4):534-538. PubMed ID: 23375512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Number of Ratings Needed for Valid Pain Assessment in Clinical Trials: Replication and Extension.
    Jensen MP; Castarlenas E; Tomé-Pires C; de la Vega R; Sánchez-Rodríguez E; Miró J
    Pain Med; 2015 Sep; 16(9):1764-72. PubMed ID: 26178637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The meaning of global outcome measures in pain clinical trials: more than just change in pain intensity.
    Jensen MP; Wang W; Potts SL; Gould EM
    Clin J Pain; 2013 Apr; 29(4):289-95. PubMed ID: 23042473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability and validity of individual and composite recall pain measures in patients with cancer.
    Jensen MP; Wang W; Potts SL; Gould EM
    Pain Med; 2012 Oct; 13(10):1284-91. PubMed ID: 22925436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized, Double-blind, Placebo-Controlled Crossover Trial of Oxymorphone Hydrochloride and Propoxyphene/Acetaminophen Combination for the Treatment of Neurogenic Claudication Associated With Lumbar Spinal Stenosis.
    Markman JD; Gewandter JS; Frazer ME; Murray NM; Rast SA; McDermott MP; Chowdhry AK; Tomkinson EJ; Pilcher WH; Walter KA; Dworkin RH
    Spine (Phila Pa 1976); 2015 May; 40(10):684-91. PubMed ID: 25705958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing Pain Intensity Assessment in Clinical Trials: How Many Ratings are Needed to Best Balance the Need for Validity and to Minimize Assessment Burden?
    de la Vega R; Sakulsriprasert P; Miró J; Jensen MP
    J Pain; 2024 Jul; 25(7):104474. PubMed ID: 38232864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using multiple daily pain ratings to improve reliability and assay sensitivity: how many is enough?
    Heapy A; Dziura J; Buta E; Goulet J; Kulas JF; Kerns RD
    J Pain; 2014 Dec; 15(12):1360-5. PubMed ID: 25283469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pain quality response profile of oxymorphone extended release in the treatment of low back pain.
    Gould EM; Jensen MP; Victor TW; Gammaitoni AR; White RE; Galer BS
    Clin J Pain; 2009 Feb; 25(2):116-22. PubMed ID: 19333156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH; Gould E
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of pain intensity in clinical trials: individual ratings vs composite scores.
    Jensen MP; Tomé-Pires C; Solé E; Racine M; Castarlenas E; de la Vega R; Miró J
    Pain Med; 2015 Jan; 16(1):141-8. PubMed ID: 25280226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postsurgical pain outcome assessment.
    Jensen MP; Chen C; Brugger AM
    Pain; 2002 Sep; 99(1-2):101-9. PubMed ID: 12237188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain.
    Katz N; Rauck R; Ahdieh H; Ma T; Gerritsen van der Hoop R; Kerwin R; Podolsky G
    Curr Med Res Opin; 2007 Jan; 23(1):117-28. PubMed ID: 17257473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketorolac, Oxymorphone, Tapentadol, and Tramadol: A Comprehensive Review.
    Vadivelu N; Chang D; Helander EM; Bordelon GJ; Kai A; Kaye AD; Hsu D; Bang D; Julka I
    Anesthesiol Clin; 2017 Jun; 35(2):e1-e20. PubMed ID: 28526155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: a one-year study.
    McIlwain H; Ahdieh H
    Am J Ther; 2005; 12(2):106-12. PubMed ID: 15767827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term tolerability and effectiveness of oxymorphone extended release in patients with cancer.
    Slatkin NE; Rhiner MI; Gould EM; Ma T; Ahdieh H
    J Opioid Manag; 2010; 6(3):181-91. PubMed ID: 20642247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative reliability and validity of chronic pain intensity measures.
    Jensen MP; Turner JA; Romano JM; Fisher LD
    Pain; 1999 Nov; 83(2):157-62. PubMed ID: 10534586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial.
    Matsumoto AK; Babul N; Ahdieh H
    Pain Med; 2005; 6(5):357-66. PubMed ID: 16266356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negligible analgesic tolerance seen with extended release oxymorphone: a post hoc analysis of open-label longitudinal data.
    Harden RN; Gagnon CM; Graciosa J; Gould EM
    Pain Med; 2010 Aug; 11(8):1198-208. PubMed ID: 20609129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.